Literature DB >> 18988901

Counterbalancing forces: what is thrombospondin-1 doing in atherosclerotic lesions?

Olga I Stenina, Edward F Plow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18988901      PMCID： PMC2752854          DOI： 10.1161/CIRCRESAHA.108.188870

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  24 in total

1.  Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.

Authors:  N Guo; H C Krutzsch; J K Inman; D D Roberts
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  Thrombospondin-1 induces DNA synthesis and migration in human vascular smooth muscle cells.

Authors:  M K Patel; G F Clunn; J S Lymn; A D Hughes
Journal:  Biochem Soc Trans       Date:  1996-08       Impact factor: 5.407

3.  The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.

Authors:  S Schultz-Cherry; J Lawler; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

4.  Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix.

Authors:  E A Jaffe; J T Ruggiero; L K Leung; M J Doyle; P J McKeown-Longo; D F Mosher
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

5.  Interaction of platelet-derived growth factor with thrombospondin 1.

Authors:  P J Hogg; K A Hotchkiss; B M Jiménez; P Stathakis; C N Chesterman
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis.

Authors:  K Gupta; P Gupta; R Wild; S Ramakrishnan; R P Hebbel
Journal:  Angiogenesis       Date:  1999       Impact factor: 9.596

7.  Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice.

Authors:  Rute Moura; Marc Tjwa; Petra Vandervoort; Soetkin Van Kerckhoven; Paul Holvoet; Marc F Hoylaerts
Journal:  Circ Res       Date:  2008-09-25       Impact factor: 17.367

8.  Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin.

Authors:  J McPherson; H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

9.  Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat.

Authors:  Olga I Stenina; Irene Krukovets; Kai Wang; Zhongmin Zhou; Farhad Forudi; Marc S Penn; Eric J Topol; Edward F Plow
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

10.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539
View more
  11 in total

Review 1.  The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

Authors:  David D Roberts; Thomas W Miller; Natasha M Rogers; Mingyi Yao; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

2.  Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells.

Authors:  Vsevolod Y Polotsky; Vladimir Savransky; Shannon Bevans-Fonti; Christian Reinke; Jianguo Li; Dmitry N Grigoryev; Larissa A Shimoda
Journal:  Physiol Genomics       Date:  2010-03-02       Impact factor: 3.107

3.  TSP-1 (Thrombospondin-1) Deficiency Protects ApoE-/- Mice Against Leptin-Induced Atherosclerosis.

Authors:  Rituparna Ganguly; Saugat Khanal; Amy Mathias; Shreya Gupta; Jason Lallo; Soumyadip Sahu; Vahagn Ohanyan; Aakaash Patel; Kyle Storm; Sujay Datta; Priya Raman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

4.  HDAC9 Polymorphism Alters Blood Gene Expression in Patients with Large Vessel Atherosclerotic Stroke.

Authors:  Natasha Shroff; Bradley P Ander; Xinhua Zhan; Boryana Stamova; DaZhi Liu; Heather Hull; Farah R Hamade; Cheryl Dykstra-Aiello; Kwan Ng; Frank R Sharp; Glen C Jickling
Journal:  Transl Stroke Res       Date:  2018-04-13       Impact factor: 6.800

5.  Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology.

Authors:  Bhairavi Swaminathan; Haize Goikuria; Reyes Vega; Alfredo Rodríguez-Antigüedad; Antonio López Medina; María del Mar Freijo; Koen Vandenbroeck; Iraide Alloza
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

6.  Thrombospondin1 deficiency attenuates obesity-associated microvascular complications in ApoE-/- mice.

Authors:  Hasiyeti Maimaitiyiming; Kate Clemons; Qi Zhou; Heather Norman; Shuxia Wang
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 7.  Thrombospondins: A Role in Cardiovascular Disease.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2017-07-17       Impact factor: 5.923

8.  Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE-/- mice.

Authors:  Rituparna Ganguly; Soumyadip Sahu; Vahagn Ohanyan; Rebecca Haney; Ronaldo J Chavez; Shivani Shah; Siri Yalamanchili; Priya Raman
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

Review 9.  Thrombospondin 1 in Metabolic Diseases.

Authors:  Linda S Gutierrez; Jovita Gutierrez
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

Review 10.  Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells.

Authors:  Priya Raman; Saugat Khanal
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.